Permeability of lipophilic compounds in drug discovery using in-vitro human absorption model, Caco-2
- 6 June 2001
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 222 (1) , 77-89
- https://doi.org/10.1016/s0378-5173(01)00698-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Effect of Restricted Conformational Flexibility on the Permeation of Model Hexapeptides Across Caco-2 Cell MonolayersPharmaceutical Research, 1997
- Caco-2 monolayers in experimental and theoretical predictions of drug transportAdvanced Drug Delivery Reviews, 1996
- The use of the intestinal epithelial cell culture model, Caco-2, in pharmaceutical developmentAdvanced Drug Delivery Reviews, 1996
- Absorption of Cam-2445, an NK1 Neurokinin Receptor Antagonist: In Vivo, In Situ, and In Vitro EvaluationsJournal of Pharmaceutical Sciences, 1996
- The Use of Surfactants to Enhance the Permeability of Peptides Through Caco-2 Cells by Inhibition of an Apically Polarized Efflux SystemPharmaceutical Research, 1996
- Age-dependent Expression of P-Glycoprotein gp17O in Caco-2 Cell MonolayersPharmaceutical Research, 1996
- Evidence for a Polarized Efflux System in Caco-2 Cells Capable of Modulating Cyclosporine A TransportBiochemical and Biophysical Research Communications, 1993
- Comparison of the Permeability Characteristics of a Human Colonic Epithelial (Caco-2) Cell Line to Colon of Rabbit, Monkey, and Dog Intestine and Human Drug AbsorptionPharmaceutical Research, 1993
- Permeable support type influences the transport of compounds across Caco-2 cellsInternational Journal of Pharmaceutics, 1992
- Dissociation and Association Rate Constants Changes following Bilirubin Binding Affinity DecreasesDevelopmental Pharmacology and Therapeutics, 1987